Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 15;5(4):S59-S83.
doi: 10.21980/J85352. eCollection 2020 Oct.

Agitated Psychiatric Patient

Affiliations

Agitated Psychiatric Patient

Brooke M Pabst et al. J Educ Teach Emerg Med. .

Abstract

Audience: This scenario was developed to educate emergency medicine residents about the diagnosis and management of the agitated psychiatric patient.

Introduction: The prevalence of agitation among patients in the emergency department is increasing, with an estimated 1.7 million events occurring annually in the United States.1 There are various methodologies for de-escalation, including verbal and chemical de-escalation and physical restraints. Chemical and/or physical restraints are sometimes necessary to ensure patient and staff safety when verbal de-escalation is ineffective, particularly since agitation is the leading cause of hospital staff injuries.2 Chemical restraints have been shown to be less physically traumatizing to patients.3 4 Adverse events associated with physical restraints include persistent psychological distress, blunt chest trauma, aspiration, respiratory depression, and asphyxiation leading to cardiac arrest.5 In regards to chemical restraints, adverse event reporting has been heterogeneous among studies, but the most consistent reported events involve respiratory compromise such as desaturation, airway obstruction, and respiratory depression.3 A study measuring QTc (corrected QT interval) after high-dose intramuscular ziprasidone or haloperidol did not demonstrate any QTc longer than 480 msec.6 Other events linked to chemical restraints include uncommon cardiovascular events and extrapyramidal side effects from medications.3 The main classes of medications utilized for chemical restraint include first-generation antipsychotics (eg, haloperidol and droperidol), second-generation antipsychotics (olanzapine, quetiapine, risperidone, aripiprazole, and ziprasidone), benzodiazipenes (eg, lorazepam and midazolam), and N-methyl-D-aspartic acid (NMDA) receptor antagonists (eg, ketamine).7,8 It is important to exclude other medical causes of agitation, consider the differential diagnoses, and then select a medication that is tailored to address underlying etiologies while remaining cognizant of the side effect profiles of these chemical agents.Educational Objectives: At the conclusion of the simulation session, learners will be able to: 1) Obtain a relevant focused history and physical examination on the agitated psychiatric patient. 2) Develop a differential for the agitated psychiatric patient, including primary psychiatric conditions and other organic pathologies. 3) Discuss the management of the agitated psychiatric patient, including the different options available for chemical sedation. 4) Prioritize safety of self and staff when caring for an agitated psychiatric patient.

Educational methods: This session was conducted using simulation with a standardized patient, followed by a debriefing session and lecture on the presentation, differential diagnosis, and management of the agitated psychiatric patient. Debriefing methods may be left to the discretion of participants, but the authors have utilized advocacy-inquiry techniques. This scenario may also be run as an oral board examination case.

Research methods: The residents are provided a survey at the completion of the debriefing session to rate different aspects of the simulation, as well as provide qualitative feedback on the scenario. This survey is specific to the local institution's simulation center.

Results: Feedback from the residents was overwhelmingly positive, although many stated that they felt some degree of intimidation or stress from the standardized patient who did not break from their role throughout the scenario.The local institution's simulation center feedback form is based on the Center of Medical Simulation's Debriefing Assessment for Simulation in Healthcare (DASH) Student Version Short Form9 with the inclusion of required qualitative feedback if an element was scored less than a 6 or 7. This session received mostly 7 scores (extremely effective/outstanding).

Discussion: This is a physically safe method for reviewing management of the agitated psychiatric patient. There are multiple potential presentations of the agitated psychiatric patient, as well as varying underlying etiologies. These scenarios may be tailored to the needs of the learner, including identifying agitation, pharmacologic review, and de-escalation techniques.

Topics: Medical simulation, agitated psychiatric patient, chemical sedation, verbal de-escalation, emergency medicine, psychiatry.

PubMed Disclaimer

Similar articles

  • Lightning Strike.
    Powell T, Charnigo A, Yee J. Powell T, et al. J Educ Teach Emerg Med. 2022 Jan 15;7(2):S78-S106. doi: 10.21980/J8SD2M. eCollection 2022 Apr. J Educ Teach Emerg Med. 2022. PMID: 37465437 Free PMC article.
  • Spinal Epidural Abscess.
    Luo CT, Yee J. Luo CT, et al. J Educ Teach Emerg Med. 2020 Jan 15;5(1):S26-S52. doi: 10.21980/J8T938. eCollection 2020 Jan. J Educ Teach Emerg Med. 2020. PMID: 37465609 Free PMC article.
  • Cardiac Tamponade.
    Chu A, Yee J. Chu A, et al. J Educ Teach Emerg Med. 2020 Oct 15;5(4):S84-S107. doi: 10.21980/J81D1D. eCollection 2020 Oct. J Educ Teach Emerg Med. 2020. PMID: 37465332 Free PMC article.
  • Pharmacological management of acute agitation.
    Battaglia J. Battaglia J. Drugs. 2005;65(9):1207-22. doi: 10.2165/00003495-200565090-00003. Drugs. 2005. PMID: 15916448 Review.
  • Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. Alexopoulos GS, et al. J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.

References

    1. Wong AH, Crispino L, Parker J, et al. Use of sedatives and restraints for treatment of agitation in the emergency department. Am J Emerg Med. 2019;37(7):1376–1379. doi: 10.1016/j.ajem.2018.12.027. - DOI - PubMed
    1. Holloman GH, Zeller SL. Overview of project BETA: best practices in evaluation and treatment of agitation. West J Emerg Med. 2012;13(1):1–2. doi: 10.5811/westjem.2011.9.6865. - DOI - PMC - PubMed
    1. Korczak V, Kirby A, Gunja N. Chemical agents for the sedation of agitated patients in the ED: a systematic review. Am J Emerg Med. 2016;34(12):2426–2431. doi: 10.1016/j.ajem.2016.09.025. - DOI - PubMed
    1. Dubin WR, Feld JA. Rapid tranquilization of the violent patient. Am J Emerg Med. 1989;7(3):313–320. doi: 10.1016/0735-6757(89)90179-4. - DOI - PubMed
    1. Wong AH, Crispino L, Parker JB, et al. Characteristics and severity of agitation associated with use of sedatives and restraints in the emergency department. J Emerg Med. 2019;57(5):611–619. doi: 10.1016/j.jemermed.2019.07.019. - DOI - PubMed